Skip to content

Twist Bioscience

US · TWST #1258 by market cap Listed 2018
103.32 -8.30 -7.44%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:52

About Twist Bioscience

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Founded
2013
CEO
Dr. Emily M. Leproust, PhD
Employees
979
Headquarters
San Francisco, California, United States of America
Fiscal year end
09-30
Website
twistbioscience.com

Company profile

Exchange
US
Symbol
TWST
Market-cap rank
#1258
Listing date
2018-10-31
Market cap
6.85B
Float cap
6.77B
Shares out
66.30M
Float shares
65.48M

Sectors & themes

ARK Portfolio AI medical concept stocks Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:52:04 · For reference only, not investment advice and not tailored to your situation.

Twist Bioscience discussion 0 comments

Add a comment